Tsukuba, Japan

Toshihiro Kogure

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1995-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Toshihiro Kogure

Introduction

Toshihiro Kogure is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of adhesive patches for medical treatments. With a total of 4 patents to his name, Kogure's work has had a meaningful impact on healthcare solutions.

Latest Patents

Kogure's latest patents include a nail patch designed to treat nail infections. This innovative nail patch comprises a backing layer and a pressure-sensitive adhesive layer, which contains a pressure-sensitive adhesive base, terbinafine, and sodium acetate as a solubilizer. Another significant invention is an adhesive patch specifically for the treatment of tinea unguium. This patch is intended for daily application and contains terbinafine in a precise concentration, ensuring effective treatment while maintaining safety levels in the plasma.

Career Highlights

Throughout his career, Toshihiro Kogure has worked with prominent companies such as Hisamitsu Pharmaceutical Company, Inc. and Nippon Sheet Glass Company, Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the pharmaceutical industry.

Collaborations

Kogure has collaborated with esteemed colleagues, including Arata Toshimitsu and Tomoyasu Shimizu. These partnerships have fostered a creative environment that has led to the development of effective medical solutions.

Conclusion

Toshihiro Kogure's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to improving healthcare. His work continues to influence the industry and offers promising solutions for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…